Detalles de la búsqueda
1.
A phase IIa study of afuresertib, an oral pan-AKT inhibitor, in patients with Langerhans cell histiocytosis.
Pediatr Blood Cancer
; 64(5)2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27804235
2.
First-in-Human Study for a Selective Rearranged During Transfection Tyrosine Kinase Inhibitor, GSK3352589, to Investigate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers.
Clin Pharmacol Drug Dev
; 10(4): 334-345, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33606922
3.
A Phase 1 Randomized, Placebo-Controlled Trial With a Topical Inhibitor of Stearoyl-Coenzyme A Desaturase 1 Under Occluded and Nonoccluded Conditions.
Clin Pharmacol Drug Dev
; 8(3): 270-280, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30650256
4.
First-in-Human Studies for a Selective RET Tyrosine Kinase Inhibitor, GSK3179106, to Investigate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers.
Clin Pharmacol Drug Dev
; 8(2): 234-245, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30277655
Resultados
1 -
4
de 4
1
Próxima >
>>